StockTipsArenaBeta

BUY Advanced Enzyme Technologies Limited — Ansh Jogendra Bhilwar

BUYAdvanced Enzyme Technologies Limited
Advanced Enzyme Technologies share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: Intraday2 Nov 2026, 8:00 am ISTvia Zee Business (Live)

Entry₹271Inferred
Target₹273
Total upside +0.74% (call closed)
Stop loss₹260-4.06% risk
Exit₹2732 Nov 2026, 9:17 am
Target hit+0.74%0.00%upside left
Follow Ansh Jogendra Bhilwar for new calls(17% target hit, 145 closed calls)Get alertsWatch ADVENZYMES for new buy/sell callsGet alertsSee 1 active Intraday pick this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Nov 2026
1 supporting3 neutral0 opposing
Supports the BUY call (1)

Advanced Enzyme Technologies reported Q2 FY27 consolidated revenue of INR 2,145 million, up 16% YoY, and PAT of INR 512 million, up 14% YoY, driven by growth across all business segments.

BSE · Company Update·31 Oct · yesterday

(opens in new tab)
Neutral / worth noting (3)

Advanced Enzyme Technologies Ltd has issued a post-buyback public announcement regarding its share buyback program.

BSE · Company Update·31 Oct · yesterday

(opens in new tab)

The board approved the company's unaudited financial results.

BSE · Board Meeting·31 Oct · yesterday

(opens in new tab)

Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·31 Oct · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Advanced Enzyme Technologies

All analyst calls on Advanced Enzyme Technologies

More from Ansh Jogendra Bhilwar

Every call and its outcome